Nuvo Research Inc. and Galderma Pharma, S.A. launched Pliaglis (lidocaine and tetracaine) Cream 7%/7% in Europe. Nuvo has licensed worldwide marketing rights for Pliaglis to Galderma, and licenses have been issued in 14 of the 16 European countries listed in the European Marketing Application for Pliaglis. Pliaglis is a topical local anesthetic cream that forms a pliable peel on the skin when exposed to air. In the E.U., Pliaglis is indicated in adults to produce local dermal anesthesia on intact skin prior to dermatological procedures. Galderma launched Pliaglis in Argentina in 2011 and in the U.S. in March 2013.